TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab.

Federico Innocenti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.